JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.77% |
| 2 | Technology | 12.5% |
| 3 | Healthcare | 9.29% |
| 4 | Consumer Discretionary | 8.66% |
| 5 | Industrials | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIOX
4101
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $244K | ﹤0.01% |
22,903
+22,028
| +2,517% | +$354K |
|
|
CO
4102
DELISTED
Global Cord Blood Corporation
CO
| $244K | ﹤0.01% |
23,929
-93,286
| -80% | -$953K |
|
4103
Invesco DB Precious Metals Fund
DBP
$259M
| $243K | ﹤0.01% |
6,279
+6,020
| +2,324% | +$235K |
|
|
OXFD
4104
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $243K | ﹤0.01% |
19,554
+14,092
| +258% | +$172K |
|
4105
Hess Midstream
HESM
$5.13B
| $242K | ﹤0.01% |
12,700
+426
| +3% | +$8.77K |
|
4106
CALL
Tapestry
TPR
$26.4B
| $242K | ﹤0.01% |
4,600
| – | – |
|
|
4107
PUT
Tapestry
TPR
$26.4B
| $242K | ﹤0.01% |
4,600
-67,300
| -94% | -$3.32M |
|
4108
BCB Bancorp
BCBP
$163M
| $241K | ﹤0.01% |
15,406
-2,152
| -12% | -$33.1K |
|
4109
Ionis Pharmaceuticals
IONS
$9.27B
| $240K | ﹤0.01% |
5,456
-56,651
| -91% | -$2.88M |
|
4110
Theravance Biopharma
TBPH
$878M
| $240K | ﹤0.01% |
9,892
-289
| -3% | -$7.94K |
|
|
FCT
4111
DELISTED
First Trust Senior Floating Rate Income Fund II
FCT
| $239K | ﹤0.01% |
18,099
+5,272
| +41% | +$68.1K |
|
4112
iShares US Utilities ETF
IDU
$1.38B
| $239K | ﹤0.01% |
3,750
-18,788
| -83% | -$1.18M |
|
4113
FB Financial Corp
FBK
$3.11B
| $238K | ﹤0.01% |
5,856
+2,249
| +62% | +$94K |
|
|
FTD
4114
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $238K | ﹤0.01% |
65,155
-36,786
| -36% | -$221K |
|
4115
PUT
Target
TGT
$70.3B
| $236K | ﹤0.01% |
+3,400
| New | +$247K |
|
4116
Global Net Lease
GNL
$1.89B
| $235K | ﹤0.01% |
13,931
-13,752
| -50% | -$242K |
|
4117
Sturm, Ruger & Co
RGR
$600M
| $235K | ﹤0.01% |
4,460
+419
| +10% | +$21.3K |
|
4118
Mizuho Financial
MFG
$134B
| $234K | ﹤0.01% |
63,315
-140,242
| -69% | -$528K |
|
|
MRCC
4119
DELISTED
Monroe Capital Corp
MRCC
| $234K | ﹤0.01% |
18,989
+16,389
| +630% | +$219K |
|
|
TNH
4120
DELISTED
Terra Nitrogen
TNH
| $234K | ﹤0.01% |
2,789
-1,372
| -33% | -$115K |
|
4121
Ovid Therapeutics
OVID
$521M
| $233K | ﹤0.01% |
33,006
+27,343
| +483% | +$221K |
|
|
PPLT
4122
abrdn Physical Platinum Shares ETF
PPLT
$2.01B
| $233K | ﹤0.01% |
26,250
-193,230
| -88% | -$1.8M |
|
|
INWK
4123
DELISTED
InnerWorkings, Inc.
INWK
| $233K | ﹤0.01% |
25,745
-15,892
| -38% | -$150K |
|
4124
Equity Bancshares
EQBK
$1.06B
| $232K | ﹤0.01% |
5,914
-4,993
| -46% | -$185K |
|
|
ARAV
4125
DELISTED
Aravive, Inc. Common Stock
ARAV
| $232K | ﹤0.01% |
23,445
-37,129
| -61% | -$418K |
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,570 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.